Product Information
METRONIDAZOLE 250 MG TABLET is a generic product labeled by BluePoint Laboratories, priced at $0.1007 per EA under NDC 68001036400. Its NADAC has been published 398 times since Nov 14, 2018.
Strength
250 mg/1
Manufacturer
BluePoint LaboratoriesNDC
68001036400
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
METRONIDAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA203458On Market Since
8/1/2018
Pharmacological Classes
Price Statistics
The NADAC for METRONIDAZOLE 250 MG TABLET has been published 398 times since Nov 14, 2018, and over the history we have for it it has declined 42.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1007 per EA |
|---|---|
| All-time high | $0.2230 (Apr 15, 2020) |
| All-time low | $0.0623 (Dec 17, 2025) |
| 52-week high | $0.1096 |
| 52-week low | $0.0623 |
| Median price | $0.1166 |
| Average price | $0.1224 |
| Largest weekly change | +36.9% (May 22, 2019) |
| Weeks tracked | 398 |
| Tracking since | Nov 14, 2018 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of METRONIDAZOLE 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METRONIDAZOLE 250 MG TABLET, manufactured by BluePoint Laboratories, is $0.1007 per EA (NDC 68001036400), effective Jun 24, 2026.
How has the price of METRONIDAZOLE 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for METRONIDAZOLE 250 MG TABLET has declined 42.4%. It has been tracked across 398 weekly CMS publications since Nov 14, 2018.
What are the highest and lowest recorded NADAC prices for METRONIDAZOLE 250 MG TABLET?
Since Nov 14, 2018, the NADAC for METRONIDAZOLE 250 MG TABLET has ranged from a low of $0.0623 (Dec 17, 2025) to a high of $0.2230 (Apr 15, 2020), with a median of $0.1166 per EA.
Are there cheaper alternatives to METRONIDAZOLE 250 MG TABLET?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, METRONIDAZOLE 250 MG TABLET, is $0.0970 per EA — about 4% below METRONIDAZOLE 250 MG TABLET.
Who manufactures METRONIDAZOLE 250 MG TABLET?
METRONIDAZOLE 250 MG TABLET (NDC 68001036400) is labeled by BluePoint Laboratories, and CMS classifies it as a generic product.
Related Drugs
Same classification